Advertisement

AIDS and Behavior

, Volume 8, Issue 2, pp 151–163 | Cite as

Long-Term Quality-of-Life Outcomes Among Adults Living with HIV in the HAART Era: The Interplay of Changes in Clinical Factors and Symptom Profile

  • Robert W. BurgoyneEmail author
  • Sean B. Rourke
  • Dean M. Behrens
  • Irving E. Salit
Article

Abstract

Changes in quality-of-life perceptions and their relations to clinical status for 41 adult outpatients living with HIV/AIDS were assessed over a 4-year period. Clinical variables and quality-of-life (Medical Outcomes Study Short-Form-36) ratings were measured in three waves (T1, 1997; T2, 1999; T3, 2001). Mean T1–T3 CD4 increase was 196 cells/μL (p < .0001), corresponding to a mean viral load reduction of 1.4 log10 copies/mL (p < .0001) and an increase in proportions with “undetectable” viral load status from 32% to 61% (p < .01). The T1–T2 increase in overall mean number of symptoms (including both disease–related symptom complex and treatment side effects) was mitigated by T2–T3 symptom reduction. Quality-of-life dimensions were generally stable or slightly improved over time for the overall sample, a finding that contrasts with pre-highly active antiretroviral therapy longitudinal research. Mental aspects of quality of life remained consistently lower than reference norms. Results of multiple regression suggested that quality of life was less sensitive to immunologic/virologic changes compared to responsiveness to symptom changes, consistent with cross-sectional inverse relations between symptom burden and quality of life. CD4 repletion offset negative effects of symptoms for some aspects of quality of life. The long-term course of quality of life was somewhat predicted by viral load suppression due to the conjoint influence of symptoms and CD4 count.

Quality of life HIV/AIDS HAART antiretroviral therapy clinical outcome 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Badia, X., Podzamczer, D., Garcia, M., Lopez-David, C., and Consiglio, E. (1999). A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients. AIDS, 13, 1727-1735.Google Scholar
  2. Bassetti, S., Battegay, M., Furrer, H., Rickenback, M., Flepp, M., Kaiser, L., Telenti, A., Vernazza, P. L., Bernasconi, E., and Sudre, P. (1999). Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued?; Journal of AIDS, 21, 114-119.Google Scholar
  3. Burgoyne, R. W., and Saunders, D. S. (2001). Quality of life among urban Canadian HIV/AIDS clinic outpatients. International Journal of STD and AIDS, 12, 505-512.Google Scholar
  4. Carrieri, P., Spire, B., Duran, S., Katlama, C., Peyramond, D., Francois, C., Chene, G., Lang, J. M., Moatti, J. P., and Leport, C. (2003). Health-related quality of life after 1 year of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 32, 38-47.Google Scholar
  5. Catz, S. L., Kalichman, S. C., Benotsch, E. G., Miller, J., and Suarez, T. (2001). Anticipated psychological impact of receiving medical feedback about HIV treatment outcomes. AIDS Care, 13, 631-635.Google Scholar
  6. Chan, K., and Revicki, D. A. (1998). Changes in surrogate laboratory markers, clinical endpoints, and health-related quality of life in patients infected with the human immunodeficiency virus. Evaluation and the Health Professions, 21, 265-281.Google Scholar
  7. Cohen, C., Revicki, D. A., Nabulsi, A., Sarocco, P. W., and Jiang, P. (1998). A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease. AIDS, 12, 1495-1502.Google Scholar
  8. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.) Hillsdale, NJ: Erlbaum.Google Scholar
  9. Cunningham, W. E., Shapiro, M. F., Hays, R. D., Dixon, W. J., Visscher, B. R., George, L., Ettl, M. K., and Beck, C. K. (1998). Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease. American Journal of Medicine, 104, 129-136.Google Scholar
  10. De Boer, J. B., Sprangers, M. A., Aaronson, N. K., Lange, J. M., and Van Dam, F. S. (1994). The feasibility, reliability and validity of the EORTC QLQ-C30 in assessing the quality of life of patients with a symptomatic HIV infection or AIDS. Psychology and Health, 9, 65-77.Google Scholar
  11. Gange, S. J., Jacobson, L. P., Kass, N., Bing, E., Chmiel, J. S., Zucconi, S. L., and Graham, N. M. (1996, July). Quality of life among HIV seropositive men on monotherapy and combination antiretroviral therapy [abstract We.B.3341]. Paper presented at the International Conference on AIDS, Vancouver, Canada.Google Scholar
  12. Hogg, R. S., Heath, K., Yip, B., Craib, K., O'Shaughnessy, M., Schecter, M., and Montaner, J. (1998). Improved survival among HIV-infected individuals following initiation of antiviral therapy. Journal of the American Medical Association, 279, 450-454.Google Scholar
  13. Justice, A. C., Rabeneck, L., Hays, R. D., Wu, A. W., and Bozzette, S. A. (1999). Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: A comparison with self-reported symptoms. Journal of AIDS, 21, 126-133.Google Scholar
  14. Justice, A. C., Chang, C. H., Rabeneck, L., and Zackin, R. (2001). Clinical importance of provider-reported HIV symptoms compared with patient-report. Medical Care, 39, 397-408.Google Scholar
  15. Kaplan, R. M., Anderson, J. P., Patterson, T. L., McCutchan, J. A., Weinrich, J. D., Heaton, R. K., Atkinson, J. H., Thal, L., Chandler, J., and Grant, I. (1995). Validity of the quality of well-being scale for persons with human immunodeficiency virus infection. Psychosomatic Medicine, 57, 138-147.Google Scholar
  16. Kazis, L. E., Anderson, J. J., and Meenen, R. F. (1989). Effect sizes for interpreting change in health status. Medical Care, 27, S178-S189.Google Scholar
  17. Lenderking, W. R., Gelber, R. D., Cotton, D. J., Cole, B. F., Goldhirsch, A., Volberding, P. A., and Testa, M. (1994). Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. New England Journal of Medicine, 330, 738-743.Google Scholar
  18. Low-Beer, S., Chan, K., Wood, E., Yip, B., Montaner, J. S., O'Shaughnessy, M. V., and Hogg, R. S. (2001). Health related quality of life among persons with HIV after the use of protease inhibitors. Quality of Life Research, 9, 941-949.Google Scholar
  19. Lubeck, D. P., and Fries, J. F. (1994). Changes in health status after one year for persons at-risk for and with HIV infection. Psychology and Health, 9, 79-92.Google Scholar
  20. Lubeck, D. P., and Fries, J. F. (1997). Assessment of quality of life in early stage HIV-infected persons: Data from the AIDS time-oriented health outcome study (ATHOS). Quality of Life Research, 6, 494-506.Google Scholar
  21. Murri, R., Ammassari, A., Fantoni, M., and Scoppettuolo, G. (1997). Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV health survey. Journal of AIDS and Human Retrovirology, 16, 350-356.Google Scholar
  22. Nieuwkerk, P. T., Gisolf, E. H., Colebunders, R., Wu, A. W., Danner, S. A., and Sprangers, M. A. (2000). Quality of life in asymptomatic and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. AIDS, 14, 181-187.Google Scholar
  23. Nieuwkerk, P. T., Gisolf, E. H., Reijers, M. H., Lange, J. M., Danner, S. A., and Sprangers, M. A. (2001). Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS, 15, 1985-1991.Google Scholar
  24. Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., and Holmberg, S. D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338, 853-860.Google Scholar
  25. Rabkin, J. G., Ferrando, S. J., Lin, S., Sewell, M., and McElhiney, M. (2000). Psychological effects of HAART: A 2-year study. Psychosomatic Medicine, 62, 413-422.Google Scholar
  26. Revicki, D. A., Wu, A. W., and Murray, M. I. (1995). Change in clinical status, health status, and health utility outcomes in HIV-infected patients. Medical Care, 33, AS173-AS182.Google Scholar
  27. Revicki, D. A., Moyle, G., Stellbrink, H. J., and Barker, C. (1999). Quality of life outcomes of combination zalcitabine–zidovudine, saquinavir–zidovudine and saquinavir–zalcitabine–zidovudine therapy for HIV-infected adults with CD4 counts between 50 and 350 per cubic millimeter. AIDS, 13, 851-858.Google Scholar
  28. Samsa, G., Edelman, D., Rothman, M. L., Rhys Williams, G., Lipscomb, J., and Matchar, D. (1999). Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics, 15, 141-155.Google Scholar
  29. Saunders, D. S., and Burgoyne, R. W. (2002). Evaluating health-related wellbeing outcomes among outpatient adults with human immunodeficiency virus infection in the HAART era. International Journal of STD and AIDS, 13, 683-690.Google Scholar
  30. Scott-Lennox, J. A., Mills, R. J., and Burt, M. S. (1998). Impact of zidovudine plus lamivudine or zalcitabine on health-related quality of life. Annals of Pharmacotherapy, 32, 525-529.Google Scholar
  31. Shafer, R. W., and Vuitton, D. A. (1999). Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1. Biomedicine and Pharmacotherapy, 53, 73-86.Google Scholar
  32. Tsevat, J., Solzan, J. G., Kuntz, K. M., Ragland, J., Currier, J. S., Sell, R. L., and Weinstein, M. (1996). Health values of patients infected with human immunodeficiency virus. Medical Care, 34, 44-57.Google Scholar
  33. Tsiodras, S., Mantzoros, C., Hammer, S., and Samore, M. (2000). Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: A 5-year cohort study. Archives of Internal Medicine, 160, 2050-2056.Google Scholar
  34. Vogl, D., Rosenfeld, B., Breitbart, W., Thaler, H., Passik, S., McDonald, M., and Portenoy, R. K. (1999). Symptom prevalence, characteristics, and distress in AIDS outpatients. Journal of Pain and Symptom Management, 18, 253-262.Google Scholar
  35. Wachtel, T., Piette, J., Mor, V., Stein, M., Fleishman, J., and Carpenter, C. (1992). Quality of life in persons with human immunodeficiency virus infection: Measurement by the Medical Outcomes Study Instrument. Annals of Internal Medicine, 116, 129-137.Google Scholar
  36. Ware, J. E., Snow, K. K., Kosinski, M., and Gandek, B. (1993). SF-36 Health Survey: Manual and interpretation guide. Boston: Health Institute, New England Medical Center.Google Scholar
  37. Ware, J. E., Kosinski, M., and Keller, S. D. (1994). SF-36 physical and mental health summary scales: A user's manual. Boston: Health Assessment Lab, New England Medical CenterGoogle Scholar
  38. Ware, J. E., Kosinski, M., Bayliss, M. S., McHorney, C. A., Rogers, W., and Raczek, A. (1995). Comparison of methods for the scoring and statistical analysis of SF-36 profile and summary measures: Summary of results from the Medical Outcomes Study. Medical Care, 33, AS264-AS279.Google Scholar
  39. Weinfurt, K. P., Willke, R. J., Glick, H. A., Freimuth, W. W., and Shulman, K. (2000). Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients. Medical Care, 38, 404-410.Google Scholar
  40. Wu, A. W., Rubin, H. R., Mathews, W. C., Ware, J. E., Brysk, L. T., Hardy, W. D., Bozzette, S. A., Spector, S. A., and Richman, D. D. (1991). A health status questionnaire using 30 items from the medical outcomes study. Medical Care, 29, 786-798.Google Scholar
  41. Wu, A. W., Rubin, H. R., Mathews, W. C., Brysk, L. M., Bozzette, S. A., Hardy, W. D., Atkinson, J. H., Grant, I., Spector, S. A., McCutchan, J. A., and Richman, D. D. (1993). Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection. Journal of AIDS, 6, 452-458.Google Scholar
  42. Zinkernagel, C., Ledergerber, B., Battegay, M., Cone, R. W., Vernazza, P., Hirschel, B., and Opravil, M. (2000). Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. AIDS, 13, 1587-1589.Google Scholar

Copyright information

© Plenum Publishing Corporation 2004

Authors and Affiliations

  • Robert W. Burgoyne
    • 3
    Email author
  • Sean B. Rourke
    • 2
    • 3
  • Dean M. Behrens
    • 4
  • Irving E. Salit
    • 1
    • 5
  1. 1.Immunodeficiency ClinicToronto General HospitalTorontoCanada
  2. 2.Mental Health Service and Inner City Health Research UnitSt. Michael's HospitalTorontoCanada
  3. 3.Department of PsychiatryUniversity of TorontoTorontoCanada
  4. 4.Department of SociologyUniversity of TorontoTorontoCanada
  5. 5.Department of MedicineUniversity of TorontoTorontoCanada

Personalised recommendations